Brazil's Federal Revenue seized over 700 shipments containing about 1 ton of banned peptides at Viracopos International Airport in Campinas, SP, from January to March 2026. The substances, mainly from China and Hong Kong, targeted weight loss and other uses without Anvisa approval. The operation underscores health risks and a growing illegal market.
Federal Revenue agents seized the shipments through customs risk management after spotting false content declarations. The products, in injectable powder form, were intended for weight loss, sleep improvement, memory enhancement, and aesthetics. They included unapproved substances like retatrutide, an experimental drug still in testing.
Unlike tirzepatide, the active ingredient in diabetes and weight-loss drugs like Mounjaro which is allowed in Brazil, these peptides lack Anvisa authorization. Their consumption poses public health risks due to uncontrolled origins, composition, and safety.
The operation at Viracopos International Airport bolsters customs enforcement against illegal trade in physical performance and aesthetic products. Officials emphasize its role in consumer protection.
